Arcus Biosciences, Inc. (RCUS)
23.33
+0.24
(+1.04%)
USD |
NYSE |
Dec 29, 16:00
23.35
+0.02
(+0.09%)
After-Hours: 20:00
Arcus Biosciences Shareholders Equity (Quarterly): 436.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| Actinium Pharmaceuticals, Inc. | 13.78M |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| Karyopharm Therapeutics, Inc. | -269.26M |
| Janux Therapeutics, Inc. | 976.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 974.00M |
| Total Liabilities (Quarterly) | 538.00M |
| Debt to Equity Ratio | 0.2546 |
| Current Ratio | 3.647 |
| Net Debt Paydown Yield | -1.37% |